Tandem Diabetes Care Inc

TD5A

Company Profile

  • Business description

    Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

  • Contact

    12400 High Bluff Drive
    San DiegoCA92130
    USA

    T: +1 858 366-6900

    E: [email protected]

    https://www.tandemdiabetes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    2,500

Stocks News & Analysis

stocks

What did Morningstar subscribers buy and sell during August?

Earnings season fuels trading activity.
stocks

Tesla: Shares fall as market disappointed with Cybercab launch event

We think Tesla stock is fairly valued.
stocks

The best global tech stocks to buy

These 12 undervalued technology stocks look attractive today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,989.6041.90-0.46%
CAC 408,156.67161.31-1.94%
DAX 4025,576.45431.18-1.66%
Dow JONES (US)52,380.66405.41-0.77%
FTSE 10010,670.06141.60-1.31%
HKSE25,274.9642.22-0.17%
NASDAQ26,253.34168.07-0.64%
Nikkei 22564,441.26701.52-1.08%
NZX 50 Index13,783.4535.98-0.26%
S&P 5007,636.3637.16-0.48%
S&P/ASX 2008,795.0043.00-0.49%
SSE Composite Index3,951.5110.960.28%

Market Movers